BENFVSGTBP• 6 Months (Normalized)
BENF vs GTBP (Beneficient vs GT Biopharma Inc.)
Showing Closing Date Range from Mar 29 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BENF Performance $2.9
-11.31%
Beneficient
Normalized Baseline0.00%
GTBP Performance $7.1
+1614.98%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1626.29 pts
GTBP outperforming by 1626.29 percentage points
BENFGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BENF GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | BENF Price | BENF Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $2.90 | -11.31% | $7.10 | +1614.98% | -1626.29% |
| Sep 22, 2026 | $0.54 | -83.55% | $- | - | |
| Sep 21, 2026 | $0.56 | -82.97% | $7.18 | +1634.30% | -1717.27% |
| Sep 18, 2026 | $0.56 | -82.81% | $7.16 | +1629.47% | -1712.28% |
| Sep 17, 2026 | $0.63 | -80.76% | $7.49 | +1709.18% | -1789.94% |
| Sep 16, 2026 | $0.82 | -74.95% | $7.81 | +1786.47% | -1861.42% |
| Sep 15, 2026 | $0.60 | -81.59% | $9.00 | +2073.91% | -2155.50% |
| Sep 14, 2026 | $0.81 | -75.35% | $11.63 | +2709.18% | -2784.53% |
| Sep 11, 2026 | $1.06 | -67.58% | $8.61 | +1979.71% | -2047.29% |
| Sep 10, 2026 | $1.21 | -62.94% | $6.18 | +1392.75% | -1455.69% |
| Sep 09, 2026 | $1.68 | -48.62% | $5.98 | +1344.44% | -1393.06% |
| Sep 08, 2026 | $1.80 | -45.11% | $- | - | |
| Sep 04, 2026 | $2.33 | -28.75% | $0.24 | -41.79% | +13.04% |
| Sep 03, 2026 | $2.15 | -34.25% | $0.25 | -39.13% | +4.88% |
| Sep 02, 2026 | $2.03 | -37.92% | $0.28 | -31.64% | -6.28% |
Page 1 of 9